Slocum, Gordon & Co’s Abbott ABT Stock Holding History
Bought
Maintained
Sold
Other funds holding ABT
WT
RG
DC
ATO
MMC
Slocum, Gordon & Co's ABT Position: Q2 2026 in Review
Slocum, Gordon & Co increased its Abbott (ABT) stake by 0.18% in Q2 2026, buying an estimated $639 and bringing the position to 3,807 shares worth $345K. The position accounts for 0.23% of the portfolio, ranked #49.
Slocum, Gordon & Co first reported a position in ABT in Q4 2022 and has held it in 14 quarters since. The position peaked at $578K in Q2 2025. 1,131 funds tracked by Wall St. Rank hold ABT as of Q2 2026.
- Slocum, Gordon & Co held 3,807 shares of Abbott worth $345K as of Q2 2026.
- Slocum, Gordon & Co bought 7 Abbott shares in Q2 2026, an estimated $639.
- Abbott made up 0.23% of Slocum, Gordon & Co's portfolio in Q2 2026, its #49 holding.
- Slocum, Gordon & Co first reported a position in Abbott in Q4 2022 and has held it in 14 quarters since.
- Slocum, Gordon & Co's Abbott position peaked at $578K in Q2 2025.
- 1,131 funds tracked by Wall St. Rank held Abbott as of Q2 2026.
Based on Slocum, Gordon & Co's 13F filing for Q2 2026, filed 23 Jul 2026.